Mark W. Powley

832 total citations
17 papers, 286 citations indexed

About

Mark W. Powley is a scholar working on Cancer Research, Pharmacology and Molecular Biology. According to data from OpenAlex, Mark W. Powley has authored 17 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Mark W. Powley's work include Carcinogens and Genotoxicity Assessment (11 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Mark W. Powley is often cited by papers focused on Carcinogens and Genotoxicity Assessment (11 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Mark W. Powley collaborates with scholars based in United States, United Kingdom and Switzerland. Mark W. Powley's co-authors include Gary P. Carlson, James A. Swenberg, Patricia B. Upton, Vernon E. Walker, Clay B. Frederick, Yanbin Li, Joseph J. DeGeorge, Frank D. Sistare, Karupiah Jayaraj and Hanan Ghantous and has published in prestigious journals such as Carcinogenesis, Toxicology and Chemical Research in Toxicology.

In The Last Decade

Mark W. Powley

17 papers receiving 265 citations

Peers

Countries citing papers authored by Mark W. Powley

Since Specialization

Citations

This map shows the geographic impact of Mark W. Powley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Powley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Powley more than expected).

Fields of papers citing papers by Mark W. Powley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Powley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Powley. The network helps show where Mark W. Powley may publish in the future.

Co-authorship network of co-authors of Mark W. Powley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Powley. A scholar is included among the top collaborators of Mark W. Powley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Powley. Mark W. Powley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	N-nitrosamine impurity risk assessment in pharmaceuticals: Utilizing In vivo mutation relative potency comparison to establish an acceptable intake for NTTP 2024 ·Regulatory Toxicology and Pharmacology ·Mark W. Powley, Zhanna Sobol, George E. Johnson, Robert W. Clark, (unknown), (unknown), (unknown), Mark D. Mowery, Patricia A. Escobar	8
2	Calculating qualified non-mutagenic impurity levels: Harmonization of approaches 2021 ·Regulatory Toxicology and Pharmacology ·Jessica Graham, Mark W. Powley, (unknown), Susanne Glowienke, John Nicolette, (unknown), Michelle Kenyon, Angela White, (unknown), James Harvey, Elizabeth A. Martin, (unknown), (unknown), Alejandra Trejo‐Martin, Joel P. Bercu	7
3	(Q)SAR: A Tool for the Toxicologist 2015 ·International Journal of Toxicology ·(unknown), (unknown), Naomi L. Kruhlak, Mark W. Powley, Nigel Greene	3
4	(Q)SAR assessments of potentially mutagenic impurities: A regulatory perspective on the utility of expert knowledge and data submission 2014 ·Regulatory Toxicology and Pharmacology ·Mark W. Powley	41
5	Timing of Carcinogenicity Studies and Predictability of Genotoxicity for Tumorigenicity in Anti-HIV Drug Development 2012 ·International Journal of Toxicology ·Kuei‐Meng Wu, Mark W. Powley, Hanan Ghantous	8
6	Genotoxicity of 1,3-butadiene and its epoxy intermediates. 2009 ·PubMed ·Vernon E. Walker, Dale M. Walker, Quanxin Meng, Jacob D. McDonald, Bobby R. Scott, Steven K. Seilkop, David J. Claffey, Patricia B. Upton, Mark W. Powley, James A. Swenberg, Rogene F. Henderson, (unknown)	10
7	Safety Assessment of Drug Metabolites: Implications of Regulatory Guidance and Potential Application of Genetically Engineered Mouse Models that Express Human P450s 2009 ·Chemical Research in Toxicology ·Mark W. Powley, Clay B. Frederick, Frank D. Sistare, Joseph J. DeGeorge	19
8	The importance of 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone in 3-butene-1,2-diol associated mutagenicity 2007 ·Chemico-Biological Interactions ·Mark W. Powley, Vernon E. Walker, Yutai Li, Patricia B. Upton, James A. Swenberg	7
9	Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol 2005 ·Carcinogenesis ·Mark W. Powley, Yanbin Li, Patricia B. Upton, Vernon E. Walker, James A. Swenberg	24
10	1,N²-Propanodeoxyguanosine Adducts of the 1,3-Butadiene Metabolite, Hydroxymethylvinyl Ketone 2003 ·Chemical Research in Toxicology ·Mark W. Powley, Karupiah Jayaraj, Avram Gold, Louise M. Ball, James A. Swenberg	17
11	BENZENE METABOLISM BY THE ISOLATED PERFUSED LUNG 2002 ·Inhalation Toxicology ·Mark W. Powley, Gary P. Carlson	8
12	Hepatic and pulmonary microsomal benzene metabolism in CYP2E1 knockout mice 2001 ·Toxicology ·Mark W. Powley, Gary P. Carlson	26
13	Cytochrome P450 isozymes involved in the metabolism of phenol, a benzene metabolite 2001 ·Toxicology Letters ·Mark W. Powley, Gary P. Carlson	27
14	Examination of pulmonary benzene metabolism 2001 ·Purdue e-Pubs (Purdue University System) ·Mark W. Powley	1
15	Cytochromes P450 involved with benzene metabolism in hepatic and pulmonary microsomes 2000 ·Journal of Biochemical and Molecular Toxicology ·Mark W. Powley, Gary P. Carlson	43
16	Species comparison of hepatic and pulmonary metabolism of benzene 1999 ·Toxicology ·Mark W. Powley, Gary P. Carlson	32
17	Metrics collection in code and unit test as part of continuous quality improvement 1993 ·Software Testing Verification and Reliability ·(unknown), (unknown), (unknown), Mark W. Powley, A.B. Smith	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact